Starting
Initialising…
0%
BRCA1
Final classification
Likely Benign
BRCA1 c.301+7G>A · p.?
BRCA1

The BRCA1 c.301+7G>A (NP_009225.1:p.?) variant has been reported in ClinVar, where the overall classification is Benign with expert panel review.

Gene
BRCA1
Transcript
NM_007294.4
HGVS · transcript:coding
NM_007294.4:c.301+7G>A
Consequence
N/A
GRCh38
chr17:43104861 C>T
GRCh37
chr17:41256878 C>T
Basis ClinGen ENIGMA BRCA1/BRCA2 Specification v1.2.0 final-classification framework (Table 3 override with conflicting-evidence point system)
ClinGen ENIGMA BRCA1/BRCA2 Specification v1.2.0 final-classification framework (Table 3 override with conflicting-evidence point system)
Classification rationale
PP3 BS3BP6 Likely Benign
BRCA1 c.301+7G>A

The BRCA1 c.301+7G>A (NP_009225.1:p.?) variant has been reported in ClinVar, where the overall classification is Benign with expert panel review.1 This variant is present in gnomAD, with AF 0.0000885 in v2.1 (25/282562 alleles; grpmax FAF 0.00010876) and AF 0.0000540 in v4.1 (87/1610834 alleles; grpmax FAF 0.00005311), so it is not absent from controls and does not meet BA1.2 Well-established functional evidence supports no damaging effect: ENIGMA Table 9 assigns BS3 Strong based on no aberrant splicing in two studies and a calibrated study showing no functional impact.3 In silico splicing prediction is conflicting with the functional evidence, because SpliceAI gives a maximum delta score of 0.29, which exceeds the ENIGMA PP3 threshold of 0.20 and argues against BP4.4

PP3 + BS3 + BP6 Likely Benign
3 vcep_specifications_table9_v1_2_2024_11_18vcep_supplementarytables_v1_2_2024_11_18PMID:22505045 ↗PMID:24667779 ↗
Gene diagram · NM_007294.4 · variants mapped to exon structure
BRCA1 NM_007294.4
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports benign
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 5.40093e-05; MAF= 0.00540%, 87/1610834 alleles, homozygotes = 0) and has highest observed frequency in the Ashkenazi Jewish population (AF= 0.000135199; MAF= 0.01352%, 4/29586 alleles, homozygotes = 0); grpmax FAF= 5.311e-05.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 8.84762e-05; MAF= 0.00885%, 25/282562 alleles, homozygotes = 0) and has highest observed frequency in the Ashkenazi Jewish population (AF= 0.000193013; MAF= 0.01930%, 2/10362 alleles, homozygotes = 0); grpmax FAF= 0.00010876.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.0054% · 87 / 1,610,834
      0 hom · FAF 0.0053%
      Ashkenazi Jewish
      4 / 29,586
      0.014%
      European (non-Finnish)
      77 / 1,177,260
      0.0065%
      Remaining individuals
      3 / 62,376
      0.0048%
      European (Finnish)
      3 / 63,922
      0.0047%
      + 6 not observed (Admixed American, Amish, East Asian, Middle Eastern, South Asian, African/African American)
      gnomAD v2.1
      0.0088% · 25 / 282,562
      0 hom · FAF 0.011%
      Ashkenazi Jewish
      2 / 10,362
      0.019%
      European (non-Finnish)
      21 / 128,976
      0.016%
      Remaining individuals
      1 / 7,204
      0.014%
      European (Finnish)
      1 / 25,058
      0.004%
      + 4 not observed (African/African American, Admixed American, East Asian, South Asian)
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Benign (11 clinical laboratories) and as Likely benign (3 clinical laboratories) and as Uncertain significance (1 clinical laboratory) and as Benign by ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel, ClinGen (expert panel).
      SpliceAI screenshot
      In silico
      SpliceAI predicts possible splice impact for this variant (max delta score = 0.29).
      Functional No data
      No calibrated functional assay or RNA evidence was identified for this variant.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Somatic evidence
      COSMIC
      This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant cancer hotspot.
      COSMIC ↗
      Literature · how each cited paper was used
      2papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why.
      PMID PMID:22505045
      Found
      Structured finding pending for this record — see source link.
      Applied to
      BS3 supports · met
      PMID PMID:24667779
      Found
      Structured finding pending for this record — see source link.
      Applied to
      BS3 supports · met
      Sources & reference links
      7Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC